Larvol Delta - University-of-Calgary-Joins-the-Phase-II-Trial-of-LSALT-Peptide-for-the-Treatment-of-Complications-in-Hospitalized-COVID19-Patients

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2021/01/05/2153377/0/en/University-of-Calgary-Joins-the-Phase-II-Trial-of-LSALT-Peptide-for-the-Treatment-of-Complications-in-Hospitalized-COVID-19-Patients.html

Jan 5, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next